How should a palpable, non‑tender mass just above the umbilicus be evaluated and managed?

Evaluation and Management of a Palpable Mass Just Above the Umbilicus

A palpable, non-tender mass just above the umbilicus requires immediate imaging with contrast-enhanced CT abdomen/pelvis as the primary diagnostic modality to differentiate between intra-abdominal pathology (including malignancy) and abdominal wall lesions. 1

Initial Imaging Approach

Contrast-enhanced CT is the first-line imaging study for suspected intra-abdominal masses, providing superior diagnostic accuracy for characterizing the mass origin, extent, and relationship to surrounding structures 1. The location just above the umbilicus suggests either:

• Intra-abdominal origin: Including omental metastases, mesenteric masses, or organ-based tumors
• Abdominal wall origin: Including lipomas, sarcomas, or desmoid tumors
• Umbilical-specific pathology: Including Sister Mary Joseph nodules (metastatic disease), primary umbilical tumors, or infected urachal remnants 2

Critical Diagnostic Considerations

Red Flags Requiring Urgent Evaluation

Any umbilical or periumbilical mass in an adult that persists beyond typical conservative management warrants aggressive investigation for malignancy 2. Key concerning features include:

• Progressive enlargement over weeks to months 2
• Associated discharge (serous or bloody), which may indicate Sister Mary Joseph nodule from underlying gynecologic or gastrointestinal malignancy 2
• Vascular appearance on imaging, suggesting aggressive pathology 2
• Systemic symptoms including weight loss, fever, or abdominal pain 2

Age-Specific Considerations

In elderly patients (>60 years), the differential diagnosis shifts heavily toward malignant etiologies, including metastatic disease to the umbilicus or primary aggressive tumors like liposarcoma 2. The three cases presented in the 2024 literature demonstrate this pattern clearly: two malignancies (Sister Mary Joseph nodule from ovarian cancer and liposarcoma) and one infected urachal cyst with Actinomycetes in elderly women 2.

Imaging Algorithm

Primary Imaging: CT Abdomen/Pelvis with IV Contrast

Order CT abdomen/pelvis with IV contrast immediately for any persistent periumbilical mass 1. This provides:

• Differentiation between abdominal wall and intra-abdominal origin 1
• Assessment of solid versus cystic components 1
• Evaluation for associated intra-abdominal pathology (particularly adnexal masses in women, gastrointestinal tumors) 2
• Vascular mapping to assess for aggressive features 2

Supplementary Imaging

MRI abdomen/pelvis without and with contrast serves as a problem-solving tool when:

• CT findings are indeterminate for tissue characterization 1
• The mass appears to arise from muscle or connective tissue of the abdominal wall 1
• Radiation exposure is a concern in younger patients 1

Ultrasound has limited utility as a primary modality for periumbilical masses but may be useful for:

• Initial bedside assessment of cystic versus solid nature 1
• Doppler evaluation of vascularity 2
• Guidance for tissue sampling 1

Tissue Diagnosis

Biopsy is mandatory for any mass with suspicious imaging features or that does not resolve with conservative management 2. Options include:

• Image-guided core needle biopsy (preferred for adequate tissue sampling) 2
• Excisional biopsy when the mass is small and superficial 2
• Fine-needle aspiration has limited utility due to inadequate tissue for definitive diagnosis 2

Common Pitfalls to Avoid

Do not assume a periumbilical mass is benign based solely on lack of tenderness or slow growth 2. The case series demonstrates that both Sister Mary Joseph nodules and liposarcomas can present as relatively indolent masses 2.

Do not delay imaging while attempting empiric antibiotic therapy, even if infection is suspected 2. The infected urachal cyst case required imaging to establish the diagnosis and guide drainage 2.

In women with periumbilical masses, always evaluate for gynecologic malignancy, particularly ovarian cancer, as Sister Mary Joseph nodules represent metastatic disease in 50-70% of cases when present 2.

Do not rely on ultrasound alone for definitive characterization of periumbilical masses, as CT or MRI provides superior anatomic detail and staging information 1.